Literature DB >> 27888116

HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF-κB inhibition.

Rui M Gil da Costa1, Sofia Aragão2, Magda Moutinho2, Antonieta Alvarado3, Diogo Carmo4, Fátima Casaca4, Sandra Silva4, Joana Ribeiro5, Hugo Sousa5, Rita Ferreira6, Rita Nogueira-Ferreira6, Maria João Pires7, Bruno Colaço7, Rui Medeiros5, Carlos Venâncio8, Maria Manuel Oliveira9, Margarida M S M Bastos10, Carlos Lopes11, Paula A Oliveira7.   

Abstract

Cancer patients often show a wasting syndrome for which there are little therapeutic options. Dietary polyphenols have been proposed for treating this syndrome, but their usefulness in cases associated with human papillomavirus (HPV)-induced cancers is unknown. We characterized HPV16-transgenic mice as a model of cancer cachexia and tested the efficacy of long-term oral supplementation with polyphenols curcumin and rutin. Both compounds were orally administered to six weeks-old HPV16-transgenic mice showing characteristic multi-step skin carcinogenesis, for 24weeks. Skin lesions and blood, liver and spleen inflammatory changes were characterized histologically and hematologically. Hepatic oxidative stress, skeletal muscle mass and the levels of muscle pro-inflammatory transcription factor NF-κB were also assessed. Skin carcinogenesis was associated with progressive, severe, systemic inflammation (leukocytosis, hepatitis, splenitis), significant mortality and cachexia. Curcumin and rutin totally suppressed mortality while reducing white blood cells and the incidence of splenitis and hepatitis. Rutin prevented muscle wasting more effectively than curcumin. Preservation of muscle mass and reduced hepatic inflammation were associated with down-regulation of the NF-κB canonical pathway and with reduced oxidative stress, respectively. These results point out HPV16-transgenic mice as a useful model for studying the wasting syndrome associated with HPV-induced cancers. Dietary NF-κB inhibitors may be useful resources for treating this syndrome.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cachexia; Cancer; Curcumin; HPV; NF-κB; Rutin

Mesh:

Substances:

Year:  2016        PMID: 27888116     DOI: 10.1016/j.lfs.2016.10.031

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice.

Authors:  Rita Araújo; Joana M O Santos; Mara Fernandes; Francisca Dias; Hugo Sousa; Joana Ribeiro; Margarida M S M Bastos; Paula A Oliveira; Diogo Carmo; Fátima Casaca; Sandra Silva; Rui Medeiros; Rui M Gil da Costa
Journal:  J Cancer Res Clin Oncol       Date:  2017-11-27       Impact factor: 4.553

2.  Decoding the role of inflammation-related microRNAs in cancer cachexia: a study using HPV16-transgenic mice and in silico approaches.

Authors:  Joana M O Santos; Sara Peixoto da Silva; Margarida M S M Bastos; Paula A Oliveira; Rui M Gil da Costa; Rui Medeiros
Journal:  J Physiol Biochem       Date:  2022-03-17       Impact factor: 4.158

3.  Efficacy of Curcumin on Treating Cancer Anorexia-Cachexia Syndrome in Locally or Advanced Head and Neck Cancer: A Double-Blind, Placebo-Controlled Randomised Phase IIa Trial (CurChexia).

Authors:  Tawasapon Thambamroong; Kasan Seetalarom; Siriwimon Saichaemchan; Yanisa Pumsutas; Naiyarat Prasongsook
Journal:  J Nutr Metab       Date:  2022-06-02

4.  The Cyclooxigenase-2 Inhibitor Parecoxib Prevents Epidermal Dysplasia in HPV16-Transgenic Mice: Efficacy and Safety Observations.

Authors:  Tiago Ferreira; Sandra Campos; Mónica G Silva; Rita Ribeiro; Susana Santos; José Almeida; Maria João Pires; Rui Miguel Gil da Costa; Cláudia Córdova; António Nogueira; Maria João Neuparth; Rui Medeiros; Margarida Maria da Silva Monteiro Bastos; Isabel Gaivão; Francisco Peixoto; Maria Manuel Oliveira; Paula Alexandra Oliveira
Journal:  Int J Mol Sci       Date:  2019-08-10       Impact factor: 5.923

5.  Human Papillomavirus and Coronary Artery Disease in Climacteric Women: Is There an Association?

Authors:  Luciane Maria Oliveira Brito; Haissa Oliveira Brito; Rita da Graça Carvalhal Frazão Corrêa; Clariano Pires de Oliveira Neto; Joyce Pinheiro Leal Costa; Sally Cristina Moutinho Monteiro; Flávia Castello Branco Vidal; Maria do Desterro Soares Brandão Nascimento; José Albuquerque de Figueiredo Neto; Rui Miguel Gil da Costa; Leonardo Victor Galvão-Moreira; Ismael Dale Cotrim Guerreiro da Silva
Journal:  ScientificWorldJournal       Date:  2019-06-20

6.  Human Papillomavirus 16-Transgenic Mice as a Model to Study Cancer-Associated Cachexia.

Authors:  Sara Peixoto da Silva; Joana M O Santos; Verónica F Mestre; Beatriz Medeiros-Fonseca; Paula A Oliveira; Margarida M S M Bastos; Rui M Gil da Costa; Rui Medeiros
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

7.  The Red Seaweed Grateloupia turuturu Prevents Epidermal Dysplasia in HPV16-Transgenic Mice.

Authors:  José Almeida; Tiago Ferreira; Susana Santos; Maria J Pires; Rui M Gil da Costa; Rui Medeiros; Margarida M S M Bastos; Maria J Neuparth; Ana I Faustino-Rocha; Helena Abreu; Rui Pereira; Mário Pacheco; Isabel Gaivão; Eduardo Rosa; Paula A Oliveira
Journal:  Nutrients       Date:  2021-12-17       Impact factor: 5.717

Review 8.  Pteridium spp. and Bovine Papillomavirus: Partners in Cancer.

Authors:  Beatriz Medeiros-Fonseca; Ana Lúcia Abreu-Silva; Rui Medeiros; Paula A Oliveira; Rui M Gil da Costa
Journal:  Front Vet Sci       Date:  2021-11-02

Review 9.  Role for Plant-Derived Antioxidants in Attenuating Cancer Cachexia.

Authors:  Wenlan Li; Kristy Swiderski; Kate T Murphy; Gordon S Lynch
Journal:  Antioxidants (Basel)       Date:  2022-01-18

10.  Dietary Supplementation with the Red Seaweed Porphyra umbilicalis Protects against DNA Damage and Pre-Malignant Dysplastic Skin Lesions in HPV-Transgenic Mice.

Authors:  Susana Santos; Tiago Ferreira; José Almeida; Maria J Pires; Aura Colaço; Sílvia Lemos; Rui M Gil da Costa; Rui Medeiros; Margarida M S M Bastos; Maria J Neuparth; Helena Abreu; Rui Pereira; Mário Pacheco; Isabel Gaivão; Eduardo Rosa; Paula A Oliveira
Journal:  Mar Drugs       Date:  2019-10-29       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.